Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
Clinical trial NCT00256191 · COMPLETED
Trial details
- NCT number
- NCT00256191
- Sponsor
- Cortice Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.